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Abstract The molecular correlate of hypertonicity-induced
cation channels (HICCs) and their role in proliferation vs.
apoptosis is a matter of debate. We report in this paper that, in
whole-cell patch-clamp recordings, hypertonic stress
(340→450 mosM) reversibly increased the Na+ conductance
of HepG2 cells from 0.8 to 5.8 nS. The effect was dose-
dependently inhibited by flufenamate and amiloride, known
blockers of HICCs, with some 50% efficiency at 300 μM. In
parallel, both drugs decreased HepG2 cell proliferation [in 3-
(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide
(MTT) assays and with automatic cell counting]. Small
interfering RNA (siRNA) silencing of the α-subunit of the
epithelial Na+ channel (ENaC) reduced hypertonicity-
induced Na+ currents to 60%, whereas the rate of HepG2
cell proliferation was approximately half of that of the
control. Moreover, α-ENaC siRNA inhibited the regulatory
volume increase of HepG2 cells (measured with scanning
acoustic microscopy) by 60%. In florescence-activated cell
sorting measurements, silencing of α-ENaC led to a
significant decrease in the G1 and an increase in the G2/M
phase of the cell cycle, whereas the S phase was not
changing. Finally (determined by a caspase 3/7 assay), HICC
inhibition by flufenamate and silencing of α-ENaC increased
the rate of apoptosis in HepG2 cells. It is concluded that α-
ENaC is one functional element of the HICC in HepG2 cells
and that the channel is an important mediator of cell
proliferation; likewise, HICC blockage shifts the system
from a proliferative into a rather apoptotic one. This is the
first report of a role of α-ENaC in cell proliferation.
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Introduction
It became quite evident in recent years that mechanisms of
cell volume regulation are employed in a variety of
physiological processes in addition to mere the maintenance
of cell homeostasis. Among these are the locomotion of
cells, the coordination of transport across the apical and
basal-lateral membranes in epithelia, the triggering of
metabolic processes in the liver, and most notably, the
control of cell proliferation and apoptosis [5, 23, 34].
A persistent shrinkage of a given cell the apoptotic
volume decrease (AVD), for instance, is one of the
hallmarks in the induction of programmed cell death. In
many systems, this volume change involves precisely the
same type of K+ channels as the “regulatory volume
decrease” (RVD) that cells show in response to hypotonic
cell swelling [7, 25, 30]. In both AVD and RVD, Cl−
channels may be opening in parallel, which altogether will
lead to a quasi-electroneutral export of KCl and osmotically
obliged water [5, 14, 18, 23].
A sustained volume increase, on the other hand, appears
to be one of the prerequisites for the initiation of cell
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proliferation — and, interestingly, this response employs
some typical transporters of the “regulatory volume increase”
(RVI) following hypertonic cell shrinkage, namely, Na+-K+-
2Cl− symport, Na+/H+ antiport, and the Na+-dependent
uptake of amino-acids [2, 8, 10, 19, 28].
Whenever studied in a quantitative way, hypertonicity-
induced cation channels (HICCs) have proven to be the
main mediators of the RVI of a given system [31, 32, 34].
Despite the typically low selectivity of HICCs for Na+ over
K+, activation of these channels leads to a net cation
uptake, which is mainly due to the inside negative
membrane voltage. Anions and water are following until
the process of RVI is finally achieved [31, 32, 34].
In a recent study on HeLa cells, flufenamate and Gd3+
were shown to dose-dependently decrease HICC activity. In
parallel to channel inhibition, cell proliferation was re-
duced, whereas the number of cells undergoing apoptosis
was augmented [26]. Moreover, osmotic HICC activation
rescues HeLa cells from staurosporine-induced apoptosis
[22]. Clearly, the activation of HICCs is a novel mechanism
employed in the proliferation of mammalian cells, and
given the prominent role these channels do play in cell
volume regulatory processes, it may indeed be of general
physiological significance. Unfortunately, no evidence
could be obtained so far as for the molecular correlate of
the HICC, which has been limiting the analysis to
pharmacological tools, so far.
In hepatocytes of the rat, the HICC is inhibited by
amiloride [3, 35, 36], which is the classic blocker of the
epithelial Na+ channel (ENaC) [16]. Accordingly, anti-α-
ENaC oligo-DNA [4] as well as small interfering RNA
(siRNA) [24] were found to reduce HICC currents and RVI
markedly. Also in primary human hepatocytes, the HICC is
inhibited by amiloride, but it is clearly sensitive to
flufenamate and Gd3+ as well [20]. Therefore, the putative
contribution of the ENaC to HICC architecture, in this
system, remained a matter of debate.
In the present study, α-ENaC is defined as one of the
functional elements of the HICC in human hepatoma
(HepG2) cells. In addition to its role in RVI, this ENaC
subunit is found to function as a mediator of cell proliferation,
and at the same time, it is opposing the process of apoptosis.
Accordingly, silencing of α-ENaC is stimulating apoptotic
cell death, which is accompanied by an arrest of cells in the
G2/M-phase of the cell cycle. These findings render a
channel-mediated volume increase a more general mechanism
of cell proliferation than was appreciated so far. Moreover,
with α-ENaC as bait, the complete molecular characterization
of the HICC in human hepatocytes will become feasible. And
finally, α-ENaC may actually serve as a target to reduce an
extensive proliferation of cells in the liver.
Materials and methods
Cell culture
HepG2 cells (kindly provided by Dr. D. Keppler, DKFZ,
Heidelberg, Germany) were grown in RPMI 1640 medium
(Invitrogen, Karlsruhe, Germany) fortified with 10% fetal calf
serum and penicillin/streptomycin (at 100 μg/ml, each; Invi-
trogen) under standard culture conditions (5% CO2, 37°C).
Culture flasks of 75 cm2 were used (BD Falcon, Heidelberg,
Germany), and cells were passaged once per week (when close
to confluency). For the detachment of cells, Trypsin-
ethylenediaminetetraacetic acid (EDTA) (Invitrogen) was
employed, and in the experiments, passages 3 to 17 were used.
Patch-clamp experiments
Membrane currents were determined from detached HepG2
cells in the fast whole-cell mode of the patch-clamp
technique. Pipettes had 3 to 5 MΩ and were pulled from
1.50 mm OD, 1.17 mm ID borosilicate capillaries (Harward
Apparatus, Edenbridge, UK) on a DMZ-Universal Puller
(Zeitz-Instrumente, Munich, Germany). Currents were
recorded with an Axopatch 200 A amplifier (Molecular
Devices, Union City, CA, USA), filtered at 5 kHz and
digitized at 20 kHz. The pClamp 8.0 software (Molecular
Devices) was used for control of the ramp protocol as well
as for data acquisition and analysis. Series resistance was
<5 MΩ and (by 70% to 80%) compensated for. In the
experiments, voltage ramps from −80 to +20 mV and of 1-s
duration were applied every 10 s; holding voltage was −30 mV.
The bath solution (pH 7.5) contained the following (inmM):
NaCl, 94; Na-gluconate, 6; MgCl2, 1; CaCl2, 2; tetraethylam-
monium chloride (TEA-Cl), 2; and 4-2-hydroxyethyl-1-
piperazineethanesulfonic acid (HEPES), 10. Osmolarity was
adjusted to 340 (isotonic) and 410 mosM (hypertonic) by
addition of mannitol. The pipette solution (pH 7.3, 300 mosM)
contained the following (in mM): NaCl, 26; Na-gluconate, 69;
MgCl2, 1; TEA-Cl, 2; Na2-ATP, 2; Na2-GTP, 0.5; HEPES, 10;
ethylene glycol tetraacetic acid (EGTA), 1. With these ion
gradients, the equilibrium potentials for Na+ and Cl− (as the
only permeant ions) were set at 0 and −30 mV, respectively.
Each recording was corrected for a liquid-junction potential of
8.6 mV, as it was computed with the pClamp 8.0 software.
MTT test and automatic cell counting
For the 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium
bromide (MTT) assay, HepG2 cells were cultured in plastic
96-well plates under 200 μl of growth medium and at an
initial density of 10,000 cells per well. After the first
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24 hours reference period, 30, 50, 100, or 300 μM
flufenamate and amiloride, respectively, were added, or cells
were transfected with the siRNA directed against α-ENaC.
Following 24 hours of incubation, 20 μl of 1 mg/ml MTT
was added, which is quantitatively transformed by viable
cells into the green-fluorescent formazan. After 2 hours, cells
were lysed with 150 μl isopropanol/HCl (0.05 N HCl in
100% isopropanol), and the optical density of each well was
determined at 550 nm on a Dynatech MR5000 plate reader
(Burlington, MA, USA). For each measurement, both
treatment and control, eight replicate wells were recorded.
For automatic cell counting, HepG2 cells were grown in
12-well plates under 2 ml of culture medium and at an
initial density of 200,000 cells per well. At a given time,
cells were detached from their substratum by trypsination
and counted on a Vi-CELL™ XR cell viability analyzer
(Beckmann Coulter, Fullerton, CA, USA). On the base of
trypan blue exclusion, this device also yields the amount of
dead vs. the total number of cells. For each measurement,
treatment, and control, three replicate wells were recorded.
cDNA preparation, PCR, real-time PCR, and agarose-gel
electrophoresis
Total RNA was isolated from HepG2 cells using the
RNeasy Mini Kit from Qiagen (Hilden, Germany) according
to the manufacturer’s protocol. RNA concentration and
quality were assessed spectrophotometrically on a DU 800
unit (Beckmann Coulter). RNA (1 μg) was then reversely
transcribed by means of 50 U of Superscript II RNase H
Reverse Transcriptase (Invitrogen) in a 22 μl reaction volume
containing 0.5 μg/μl oligo(dT), 10 mM deoxyribonucleotide
triphosphate (dNTP) mix, 10× reverse transcription (RT)
buffer, 25 mM MgCl2, 0.1 M dithiothreitol, and RNaseOUT
Recombinant RNase Inhibitor (Invitrogen). The RNA and
oligo(dT) mixture was heated to 65°C for 5 min, chilled on
ice, and then all other reagents were added. The reverse
transcription polymerase chain reaction (RT-PCR) was
conducted at 42°C for 50 min and at 70°C for 15 min. The
RNase H treatment was performed at 37°C for 20 min.
DNA fragments were amplified by using PCR after
Mullis et al. [21]. PCR reactions were prepared in a total
volume of 50 μl. Five units Taq DNA polymerase
(Eppendorf, Hamburg, Germany) was mixed with 1×
reaction buffer, 0.2 mM of every dNTP, 300 pM of each
primer (α-ENaC-F, CAATGACAAGAACAACTCC; α-
ENaC-R, CCACCATCATCCATAAAG; β-actin-F,
CTCGTCGTCGACAACGGCTC; β-actin-R, AGTGGTA
CGGCCAGAGGCG), and 50 ng of DNA template. PCR
reactions were performed with a Mastercycler Gradient
Thermocycler (Eppendorf) using the following program:
one cycle of 2 min at 94°C, 25 to 35 cycles of 15 s at 94°C
and 30 s at 50°C to 65°C (depending on the melting
temperature of the primers) with an elongation time at 68°C
(which was depending on the size of the DNA fragment),
and one cycle of 3 min at 68°C.
The quantitative real-time PCR was performed by means
of the GeneAmp 5700 Sequence Detection unit (Applied
Biosystems, Darmstadt, Germany) plus the QuantiTech
SYBR Green PCR kit (Quiagen). All PCR reactions were
performed in 96-well plates (Applied Biosystems) containing
0.9 μM of each primer (α-ENaC F, CTGTGCAACCAGAA
CAAATCG; α-ENaC R, CAGCCTCCACAGGATGTTGA;
β-actin F, CTGGCACCCAGCACAATG; β-actin R,
GCCGATCCACACGGAGTA), 30 to 100 ng of cDNA, and
12.5 μl of SYBR Green I (in a total reaction volume of 25 μl).
Each run included a buffer blank and a no-template control to
test for possible contaminations of assay reagents.
PCR products were analyzed by agarose gel electrophoresis
using the RAGE RGX-100 system (Cascade Biologics,
Portland, OR, USA). The DNA samples were diluted in 1×
DNA sample buffer (from a 10× stock of 50% w/v glycerol,
0.1% w/v Orange G, 0.1 mM EDTA, pH 7.4) and loaded on
0.8% to 2.0% agarose gels in 1× TAE buffer (from a 50×
stock of 2 M Tris-acetate, 0.5 M EDTA, pH 8.0) containing
0.5 μg/ml ethidiumbromide. Agarose gels were run for 15 to
20 min at 275 V. Gels were analyzed with a Gel Doc 1000
system (BioRad, Munich, Germany).
Transfection with siRNAs
Gene silencing was performed with the sequence specific α-
ENaC–siRNA duplex r(GCACCUUUGGCAUGAUGUA)d
(TT) and r(UACAUCAUGCCAAAGGUGC)d(AG) for sense
and antisense. Negative control was the non-silencing siRNA
duplex r(UAUUGGCUUACGCGCAGAU)d(TT) and r
(AUCUGCGCGUAAGCCAAUA)d(AG). siRNAs were la-
beled with Alexa Fluor 488 to monitor transfection efficiency.
Cells were seeded in 12-well plates and reached 30% to
50% confluency within 24 hours. DharmaFECT 1 (Perbio
Science, Bonn, Germany) was used as the transfection
reagent. Incubation time was 6 hours, and measurements
were started 26 to 48 hours after the transfection procedure.
Protein detection
The concentration of proteins in cell lysates was determined
following the protocol of Bradford [6] as well as by use of
the Micro BCA™ Protein Assay Kit (Perbio Science).
Bovine serum was used as the protein standard.
Protein separation was performed by discontinuous
sodium dodecyl sulfate polyacrylamide gel electrophoresis
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(SDS-PAGE) on 4% to 12% acrylamide gels with the Nu-
Page™ Bis-Tris Electrophoresis System (Invitrogen). The
40-μl probes were diluted by 10 μl of 5× sample buffer
(50 mM Tris, 10% SDS, 0.02% bromphenol blue, 10%
glycerol, 2.5% β-mercaptoethanol). The 2-(N-morpholino)
ethanesulfonic acid (MES) SDS running buffer was prepared
directly before use from a 20× stock solution (50 mM MES,
50 mM Tris, 0.1% SDS, 1 mM EDTA, pH 7.3). The
SeeBlue™ Plus2 pre-stained standard (Invitrogen) was used
as the molecular weight marker. Gels were run at 200 V for
55 min.
For the Western blots, methanol-activated polyvinylidene
difluoride (PVDF) membrane, blotting pads, and filters in
transfer buffer (20 mM Tris–HCl, 150 mM glycine, 20% v/v
methanol, 0.05% SDS, pH 7.8 to 8.4) plus the gels were
placed in the XCell II™ blot module (Invitrogen), and the
transfer was performed at a constant current of 180 mA for
45 min. Thereafter, the membrane was blocked with 5%
non-fat dry milk and 1% bovine serum albumin in TBST
(137 mM NaCl, 2.7 mM KCl, 20 mM Tris-HCl, pH 7.4,
0.1% Tween 20) overnight at 4°C. Binding of the primary
and the horseradish peroxidase-coupled secondary antibody
(monoclonal anti-α-ENaC from rabbit, diluted 1:1,000;
polyclonal anti-rabbit-IgG (H+L) from goat, diluted
1:10,000; Sigma-Aldrich, Taufkirchen, Germany) was ac-
complished in the blocking solution. Protein bands were then
visualized using Hyperfilm™ and ECL™ chemiluminis-
cence analysis system (Amersham, Buckinghamshire, UK).
Acoustic microscopy
Cell volumes (and RVI) were determined on a scanning
acoustic microscope device as it was described previously
[24, 37]. Briefly, a 400-μl experimental chamber was
placed on the stage of an inverted microscope (IX81,
Olympus, Hamburg, Germany) where it was continuously
perfused at 1.2 ml/min by means of piezo-driven micro-
pumps (Bartels Microtechnique, Dortmund, Germany).
Compositions of isotonic and hypertonic test solutions
(300 and 410 mosM, respectively) were identical to those
used in the patch-clamp recordings, and the temperature of
the perfusate was kept at 37.0±0.1°C with the use of Peltier
elements. Collagen-coated glass coverslips with sub-
confluent HepG2 cells were transferred to a stainless steel
plate with a circular aperture (positioned on the microscope
stage) and clamped to this plate with the upper (Perspex)
part of the chamber.
A 1-GHz sound wave (generated through a piezzo
element) was focused with a sapphire lens onto the HepG2
cell layer from where it was reflected twice, first from the
upper surface of a given cell and, second, from its glass
substratum. From the difference between the arrival times
of both echos at the sapphire lens (now in its detection
mode), the actual height of a cell could be determined with
an accuracy of ±50 nm. These measurements were
performed in a scanning mode of 50×50 pixels that were
set to be 2 μm apart so that a total area of 100×100 μm
(with some ten to 12 cells on it) was covered. A rapid move
of the acoustic lens was achieved using a high-definition
step-motor unit, and a scan was complete in less than 20 s.
The acoustic lens itself was occupying some 300 μl of the
experimental chamber so that a complete exchange of the
bath solutions was achieved within 20 s. In experiments
with siRNAs, only areas with cells exhibiting a distinct
Alexa Fluor 488 fluorescence were analyzed.
Cell-cycle analysis and preparative cell sorting
HepG2 cells were cultured in 12-well plates at a density of
2×105/well. Twenty-four hours after transfection with the
siRNAs, the cells were trypsinized and washed with ice-
cold phosphate-buffered saline (PBS). Following fixation
(with 2% p-formaldehyde in PBS for 10 min on ice) and
permeabilization (with 0.25% Triton X-100 in PBS for
5 min on ice), the DNA was stained with Hoechst 33258
(Sigma-Aldrich; 1.2 μg/ml for 20 min at 37°C), and cells
were directly used for the recordings, thereafter. Control
cells and those subjected to mere the transfection reagent
were treated accordingly.
The florescence-activated cell sorting (FACS) analysis
was performed on an LSR II Flow Cytometer (Becton
Dickinson, Heidelberg, Germany) using the VioFlame Plus
violet laser (25 mW, 405 nm) and the Sapphire blue laser
(20 mW, 488 nm). Excitation and emission settings were as
follows: 405 nm excitation and a 440/40 band-pass filter for
Hoechst 33258; 488 nm and a 530/30 band-pass filter for
Alexa Fluor 488. The LSR II was driven with the FACS
DiVa software (Becton Dickinson), which includes features
like reusable acquisition templates, automated compensation,
and offline compensation.
The data obtained were analyzed using the FlowJo
software (Tree Star, OR, USA), and cell cycle fractions G1,
S, and G2/M were determined from the DNA histograms
according to Stal and Baldetrop [27] (see also [1]). Special
care was taken to exclude G1 doublets, which were
discriminated from single cells using pulse height vs. pulse
area of the Hoechst signal [38]. For all flow-cytometry
experiments reported, at least 50,000 cells were analyzed,
and in most instances, the number of cells was in the range
of 70,000 to 100,000.
To test for the efficiency of α-ENaC silencing at the
protein level, those cells actually transfected with siRNA
were enriched on a FACS DiVa high-speed cell sorter
(Beckton Dickinson). Propidium iodide (PI) was added to
the cell suspension at a final concentration of 0.5 µg/ml to
identify and exclude dead cells. Cells were sorted according
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to the fluorescence of the Alexa Fluor 488 conjugated
siRNA and the absence of PI uptake, using the 488 nm
argon laser line for the excitation of the fluorochromes. A
520/20 bandpass filter was employed for the recording of
siRNA fluorescence intensity and a 630/22 bandpass filter
was used for the monitoring of PI. Cells treated only with
transfection reagent and untreated cells served as controls to
determine the levels of autofluorescence. Flow cytomet-
ric analysis of aliquots of the isolated cells confirmed
purities of more than 90%. Sorted cells (approximately
106/sample) were then transferred to an ice-cold lysis
buffer containing 100 mM NaCl, 2 mM MgCl2, 50 mM
Tris-HCl (pH 7.4), 10% glycerol, 1% Nonidet P-40,
100 μM phenylmethylsulfonyl fluoride, 1 mM benzami-
dine, 1 μg/ml leupeptin, and 7 μg/ml pepstatin. Cell debris
was removed by a 30-min centrifugation step at
100,000×g, and the protein concentration of the superna-
tant was determined according to Bradford [6]. After
addition of 5× SDS sample buffer, probes were subjected
to SDS-PAGE and Western blotting.
Apoptosis assays
For the caspase-3/7 assay, HepG2 cells were inoculated into
plastic 96-well plates at an initial density of 10,000 per
200 μl of culture medium and were reaching 50% to 60%
confluency in 24 hours. At that time, the HICC blocker
flufenamate was applied. In the second experimental group,
α-ENaC was silenced by siRNA treatment. Two micro-
molars camptothecine (a topoisomerase I inhibitor) was
used as a positive control in the caspase-3/7 assays.
After 24 hours of incubation, culture media were
removed, and an Apo-ONE™ Homogeneous Caspase-3/7
Assay (Promega, Madison, WI, USA) was conducted as
described in the manufacturer’s protocol. Fluorescence was
determined with an excitation/emission at 485/530 nm on a
plate-reader (Thermo Labsystems, Helsinki, Finland). The
CytoTox-ONE™ Assay (Promega) was used to test for a
possible leakage of cells (following the protocol of the
manufacturer). The assay is based on the fluorometric
detection of lactate dehydrogenase (LDH) in the extracel-
lular medium.
Results
Hypertonic stress activates HICC currents
In whole-cell recordings on single HepG2 cells, hypertonic
stress (340→450 mosM) increased Na+ currents (determined
at ECl=−30 mV, where Cl− currents are zero) from −23.2±
3.5 to −179.2±13.0 pA (n=16, p<0.001; Fig. 1a, b). In
addition, there was a small but significant increase in Cl−
conductance (measured at ENa, i.e., with Na
+ currents set at
null) that equaled 0.1±1.3 and 32.5±6.8 pA under isotonic
and hypertonic conditions, respectively (p<0.001; Fig. 1a, b).
Rather likely due to these parallel effects of cell shrinkage on
both types of current, zero-current voltages were very similar
under both osmotic conditions, namely, −8.3±1.7 and −6.0±
1.1 mV (see Fig. 1a). In most instances, activation of currents
was almost completely reversible upon return to the
340 mosM solution.
Flufenamate and amiloride inhibit HICC currents
Very comparable to the HICC in primary human hepatocytes
[20], Na+ currents were blocked by micromolar concen-
trations of both flufenamate and amiloride. In the first series,
hypertonicity-induced currents equaled −162.6±17.5 pA, in
the control recordings (n=12, p<0.01). With this value set as
100±10.8%, 30, 50, 100, and 300 μM flufenamate reduced
HICC currents to 79.2±6.2%, 83.8±7.0%, 68.4±7.7%
(p<0.05), and 61.4±20.7% (p<0.05), respectively (n=3 or
Fig. 1 Whole-cell patch-clamp recording on the hypertonic activation
of membrane currents in HepG2 cells. a The lower trace represents the
HICC Na+ current (determined at ECl=−30 mV, i.e., where Cl−
currents are zero), the upper trace gives the Cl− current (at ENa=0 mV,
where Na+ currents are set at null). For the time indicated, osmolarity
was increased from 340 (iso=isotonic) to 450 mosM (hyper=
hypertonic). b membrane currents in response to 1-s voltage ramps
(from −80 to +20 mV) applied at times 1, 2, and 3 in a, i.e., under iso,
hyper, and post-hyper conditions
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4; see Fig. 2a, b). Likewise, in the second series, Na+
currents were −144.9±22.9 pA in the control recordings (n=
4, p<0.001). With 30, 50, 100, and 300 μM amiloride,
HICC currents were reduced to 78.3±3.8% (p<0.01), 62.6±
15.6% (p<0.05), 53.8±14.7% (p<0.05), and 42.7±20.7% (p<
0.05), respectively (n=3 or 4; see Fig. 2c). These measure-
ments render the expression of identical HICCs in primary
human hepatocytes [20] and HepG2 cells very likely.
Furthermore, they serve as the first tool, in this study, to
correlate HICC activity and HepG2 cell proliferation (see
below).
Flufenamate and amiloride reduce the rate of HepG2 cell
proliferation
As was determined by means of an MTT enzyme assay,
HepG2 cells were proliferating to 175.7±10.2% (within an
experimental time frame of 24 hours; n=8), under control
conditions. With this value set at 100±5.8%, 30, 50, 100,
and 300 μM flufenamate led to a reduction of HepG2 cell
proliferation to 96.9±2.7%, 88.5±4.1% (p<0.05), 75.1±
4.1% (p<0.05), and −16.2±4.2% (p<0.01), respectively
(n=6; Fig. 3a). With the same concentrations of amiloride
(and 100±16.6% as the control), cell proliferation equaled
75.4±5.2% (p<0.001), 54.5±5.6% (p<0.001), 38.0±5.9%
(p<0.001), and −20.5±11.8% (p<0.001, n=7; Fig. 3b).
Next, cell proliferation was quantified by automatic cell
counting, a technique that, at the same time, is yielding the
amount of necrotic or late apoptotic cells (on the base of
intracellular trypan blue staining). As shown in Fig. 3c, 30,
50, 100, and 300 μM flufenamate reduced HepG2 cell
proliferation from 100±6.8% to 89.5±3.4% (p<0.05),
85.0±3.4% (p<0.001), 61.7±5.7% (p<0.001), and −3.0±
4.3% (p<0.001), respectively (n=6). With amiloride,
proliferation was decreased (from 100±6.8%) to 84.0±7.9%
(p<0.05), 74.8±5.8% (p<0.01), 54.7±4.5% (p<0.001), and
15.6±4.4% (p<0.001, n=6; Fig. 3d).
Concerning the amount of dead cells in the above
experiments, 9.0±2.2% were determined under control
conditions, 16.4±3.2% for flufenamate at 30 μM (n.s.),
16.4±3.5% at 50 μM (n.s.), 19.8±4.4% at 100 μM (n.s.),
and 46.1±6.1% at 300 μM (p<0.001). So quite obviously,
the flufenamate effect on HepG2 cell proliferation, at that
latter concentration, is also reflecting a necrosis or a late
phase of apoptosis of cells rather than solely a reduction of
mitotic activity. Nevertheless, at 100 μM and below, this is
clearly not the case. With 30 μM amiloride, 13.8±3.3% of
dead cells were observed (n.s.), 13.7±4.0%with 50μM (n.s.),
15.4±4.7% with 100 μM (n.s.), and 18.8±3.4% with 300 μM
(p<0.05). In other words, just some 10% of the observed
reduction in HepG2 cell proliferation, at 300 μM amiloride,
may actually reflect a necrosis or apoptosis of cells, and once
again, at 100 μM and below, this additional effect of the
compound is clearly not observed.
Decreasing α-ENaC expression by means of siRNA
The amiloride sensitivity of the HICC in HepG2 cells was
suggestive of a possible correlation to the ENaC, which just
by itself, however, is exhibiting a higher sensitivity to the
compound [16]. To test for this hypothesis, cells were
transfected with an siRNA construct directed against the α-
subunit of the ENaC, which is the central element in the
formation of epithelial Na+ channels [9, 11]. As a marker of
Fig. 2 Pharmacology of HICC currents. a Typical recording with
300 μM flufenamate that was added to the bath solution following
maximal HICC activation. b, c Summary of results obtained for
flufenamate and amiloride, respectively (n=12 and 4, for the control
conditions, and 3 or 4, for the various concentrations of both
compounds)
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transfection efficiencies (also for the flow cytometric
analysis), the siRNA was fluorescence labeled with Alexa
488. Figure 4a and b depict a phase contrast and fluorescent
micrograph of a cluster of some 40 HepG2 cells, respec-
tively, from which an efficiency of transfection of some
50% is apparent. This is in good accordance with an
amount of some 40% to 60% of transfected cells, as it was
typically monitored by flow cytometry (not shown). The
actual efficiency of α-ENaC silencing was then determined
by three independent techniques, namely PCR, quantitative
real-time PCR, as well as Western blot analysis. As shown
in Fig. 4c, the PCR experiments revealed a distinct
reduction of α-ENaC transcripts, again to some 50% of
the control value. In line with this, real-time PCR showed a
reduction of α-ENaC messenger RNA (mRNA) to 40.6±
3.2% of the reference level (n=7, p<0.001; Fig. 4d). On the
protein level, siRNA silencing led to a reduction of α-
ENaC down to some 10% to 20% of control (see Fig. 4e). It
is of note in this respect, however, that the number of
siRNA transfected cells had been enriched by means of
preparative FACS (see “Materials and methods”), in the
latter experiments. Taken together, these measurements
document an efficient silencing of α-ENaC using our
transfection protocols.
Anti-α-ENaC siRNA inhibits HICC currents
Next, the effects of α-ENaC silencing on HICC currents were
determined. One of the major observations, under these
conditions, was a shift of zero-current voltage to −14.7±
1.1 mVand −15.3±0.8 mV for the isotonic and the hypertonic
currents, respectively (n=14; Fig. 5a). This is significantly
more negative than in the control experiments (see Fig. 1b),
with p<0.01 and p<0.001. It is also more negative with
reference to an additional series of recordings performed
with control siRNA, in which reversal potentials equaled
−7.9±1.7 and −6.3±1.7 mV, under isotonic and hypertonic
conditions, respectively (with p<0.001, for both; n=6).
As shown in Fig. 5b, this shift of zero-current voltage is,
first of all, reflecting a reduction of the hypertonic Na+
conductance (computed from the currents at ECl=−30 mV),
which was 6.48±0.43 and 6.42±0.51 nS for control and
control siRNA conditions, respectively, and which was
decreased to 3.95±0.36 nS following siRNA silencing of
α-ENaC (p<0.01). This is equivalent to some 60% of the
reference values. Interestingly, comparable effects were
detectable under isotonic conditions already, where Na+
conductance was 0.78±0.13, 0.91±0.25, and 0.46±
0.06 nS, respectively, with the latter value accounting to
some 60% and 50% of the two controls (p<0.01; Fig. 5b).
In other words, not only does siRNA silencing of α-ENaC
considerably reduce hypertonicity-induced Na+ conductance,
but this channel subunit also appears to actually contribute to
the baseline properties of the HepG2 cell membrane as well.
Quite surprisingly at first sight, there was also a distinct
cross-correlation between α-ENaC siRNA silencing and the
Cl− conductance of the membrane (as it was determined from
the currents at ENa=0 mV). For the hypertonic conditions,
Cl− conductance was 1.88±0.09, 1.16±0.41, and 4.71±
0.23 nS, in the control, the control siRNA, and the α-ENaC
siRNA recordings, respectively. This latter value is equivalent
to some 250% and 400% (p<0.001; Fig. 5c), when compared
Fig. 3 Pharmacology of HepG2
cell proliferation. Experiments
were performed by means of an
MTT enzyme assay (a, b) or by
use of automatic cell counting
(c, d; see text for details), as
indicated. Data are presented
with reference to control
measurements (Ctrl) of 24 hours
each, with no compound present
(n=6 or 7)
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to the two controls. Also under isotonic conditions, this effect
was detectable: In the control, the control siRNA, and the α-
ENaC siRNA experiments, Cl− conductance was computed
as 0.20±0.08, 0.24±0.14, and 0.44±0.08 nS, respectively,
with the latter data accounting to approximately 220% and
180% of the reference values (p<0.05). Accordingly, the
observed negative shift of the zero-current voltages following
the transfection with α-ENaC siRNA (Fig. 5a) will, to a
significant extent, also be due to the increase of Cl−
conductance.
Anti-α-ENaC siRNA reduces the rate of HepG2 cell
proliferation
Next, the effect of α-ENaC siRNA silencing on the
proliferation of HepG2 cells was tested. As was determined
by means of the MTT assay, cell proliferation equaled
93.0±14.4% for the control siRNA, which is not significantly
Fig. 5 Membrane currents in HepG2 cells transfected with anti-α-ENaC
siRNA. a Typical recording. Note the negative shift in zero-current
voltage when compared to control cells (Fig. 1b). b Silencing of α-ENaC
significantly decreases Na+ conductance (measured at ECl=−30 mV),
under hypertonic stress and under isotonic conditions as well (n=14). c At
the same time, cell membrane Cl− conductance (determined at ENa=
0 mV) is increasing
Fig. 4 Efficiency of HepG2 cell transfection with anti-α-ENaC
siRNA. a A cluster of some 40 cells under phase contrast. b
Fluorescence micrograph of the same cells showing approximately
50% transfection with Alexa-488 labeled siRNA. Typical observation.
c PCR amplification of α-ENaC under control conditions (Ctrl) and
following siRNA transfection (siRNA). d siRNA silencing of α-ENaC,
as it was determined by means of real-time PCR (n=7). eWestern blot
on the efficiency of siRNA silencing. Experiments shown in c and e
are representative of a total of 3
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different from the data obtained for mere the transfection reagent
that was set as the 100.0±17.4% reference (n=5), here. In
contrast, for cells transfected with α-ENaC siRNA, prolifera-
tion was markedly reduced to 30.2±14.3% (p<0.001; Fig. 6a).
With the automatic cell counting, very similar results were
obtained: For transfection reagent, control siRNA, and α-
ENaC siRNA, HepG2 cell proliferation was 100.0±10.9%,
94.0±13.8%, and 46.7±6.8% (n=6, p<0.001; Fig. 6b),
respectively. In this latter series of experiments, the amount
of necrotic cells was found to be 16.5±2.4% for control
siRNA and 17.9±2.0% for α-ENaC, which do not statistically
differ from the value obtained for the transfection reagent,
namely, 14.4±1.6%.
Anti-α-ENaC siRNA inhibits RVI
Since in the HepG2 system, the HICC is the main
mechanism of RVI with little if any contribution of Na+/H+
exchange (NHE1) and Na+-K+-2Cl− symport (NKCC1) [33],
a significant effect of α-ENaC silencing on cell volume
regulation is to be expected. As was determined by scanning
acoustic microscopy, increasing osmolarity from 300 to
410 mosM led to an initial shrinkage of cells from 5.56±
0.22 to 4.40±0.21 pl. Within an experimental time frame of
10 min, this passive osmotic behavior was then followed by a
partial volume recovery to 4.70±0.24 pl. With reference to the
amount of cell shrinkage, this is equivalent to an RVI value of
25.8±3.0% for the control conditions (n=4, p<0.001;
Fig. 7a). These data are undistinguishable from those that
were obtained with the transfection reagent and the control
siRNA (as additional reference values), where RVI was
25.4±2.9% (n=6) and 28.8±1.6% (n=11), respectively.
Also of note, these RVI data are very similar to those reported
earlier on the base of a confocal laser-scanning protocol,
namely 26.3±0.9% [33]. In contrast, in cells that had been
transfected with α-ENaC siRNA, RVI was significantly
reduced to 8.3±0.6% (n=22, p<0.001; Fig. 7a), which is
equivalent to approximately 32% of the reference values (see
Fig. 7b). These recordings provide an additional and very
clear link between cell proliferation and RVI, and they prove
the prominent role of α-ENaC in both processes.
Fig. 7 Inhibition of HepG2 RVI by α-ENaC silencing. a Typical
recording of hypertonicity-induced volume changes in a control cell
(squares) and in a cell following siRNA treatment (circles). RVI
values were computed as percent of the initial amount of cell
shrinkage. b Summary of the results (n=4, 6, 13, and 24 for Ctrl,
TR, Ctrl siRNA, and α-ENaC siRNA, respectively)
Fig. 6 Effects of α-ENaC silencing on HepG2 cell proliferation.
Measurements were performed with the MTT assay (a n=5) or by use
of automatic cell counting (b n=6). TR transfection reagent
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Anti-α-ENaC siRNA shifts HepG2 cells from the G1
to the G2/M phase of the cell cycle
To more specifically address the reduced proliferation in
response to silencing of α-ENaC, a flow cytometric
analysis of the cell cycle distribution was performed. The
amount of HepG2 cells in the G1 phase was found to be
56.8±2.6%, 52.9±6.6%, 49.3±4.6%, and 47.2±3.7%,
respectively, for control conditions, transfection reagent,
control siRNA, and α-ENaC siRNA (n=5; Fig. 8). With
p<0.05, the latter value is significantly different from the
group of untreated cells. Concerning the S phase, the
amount of cells was very similar for the three control
conditions, i.e., 27.2±2.1%, 27.2±3.0%, and 26.9±3.0%. It
was slightly reduced to 18.7±5.0% for α-ENaC siRNA but
(with p=0.12, 0.19, and 0.15) the effect remained off
significance. Cells in the G2/M phase were 22.4±1.1%,
21.9±1.1%, and 24.2±3.3%, for control conditions, trans-
fection reagent, and the control siRNA, respectively. With
35.3±4.3%, however, there was a clear increase of the
amount of cells in the α-ENaC siRNA group (p<0.05, with
reference to each of the three controls). In other words, the
observed reduction of HepG2 cell proliferation is very
likely to reflect an actual arrest in the G2/M phase of the
cell cycle.
HICC inhibition and α-ENaC silencing stimulate apoptosis
Since it became quite obvious in recent years that
proliferation and apoptosis do interfere on the basis of cell
volume changes [5, 23, 34], we were wondering whether a
block of the HICC or the silencing of α-ENaC would
actually lead to an increased rate of HepG2 cell death. As
shown in Fig. 9a, 2 μM of the apoptosis inducer
camptothecine increased the caspase 3/7 activity in HepG2
cells from 0.86±0.34 (arbitrary units), under basal conditions,
to 2.11±0.42 (n=5; p<0.05) following a 24-hour treatment
with the compound. With these data as a positive control, we
were then testing for the putative role of flufenamate in
HepG2 apoptosis. In these experiments, caspase 3/7 activity
was 0.90±0.17 under control conditions. With 100 and
Fig. 9 Effects of flufenamate and α-ENaC silencing on HepG2 cell
apoptosis (quantified on the basis of a caspase 3/7 enzyme assay). a
Apoptosis, under control conditions and in the presence of 2 μM of
the apoptosis-inducer camptothecin (used as a positive control here).
b, c, Three hundred micromolars flufenamate as well as the silencing
of α-ENaC with a specific siRNA leads to a pronounced stimulation
of the rate of apoptosis (n=5 to 8, for each experimental condition;
significantly different from control with *p<0.05 and ***p<0.001,
respectively)
Fig. 8 Effects of α-ENaC silencing on HepG2 cell-cycle distribution.
Note the significant increase of the number of cells in G2/M-phase
following silencing of α-ENaC (n=5)
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300 μM flufenamate, 1.01±0.27 (n.s.) and 2.04±0.56
(p<0.05; n=5–8), respectively, were obtained (Fig. 9b). In
other words flufenamate, at the latter concentration, in-
creased HepG2 cell death to approximately 230% of the
reference value. Of note, within the 24 hours time frame
used, LDH release, taken as an indicator of necrotic cell
death here, was typically found to be in the range of 15% to
20% of the total cell content and did not significantly differ
between experimental groups. These data suggest that
inhibition of the HICC (and the resultant reduction of cell
proliferation) may in fact lead to an increase in HepG2 cell
apoptosis. This cross-talk is strongly supported by a final
series of measurements in which the actual effects of α-
ENaC silencing on HepG2 apoptosis was tested. With
transfection reagent and control siRNA, caspase 3/7 activity
was 1.00±0.05 and 1.17±0.08 (arbitrary units), respectively
(n=5; Fig. 9c). Following transfection with α-ENaC siRNA,
the enzyme activity was 1.51±0.06, which is significantly
higher than the two controls with p<0.001 and p<0.05,
respectively.
Discussion
In the present study, we observed an eightfold increase in
HepG2 whole-cell Na+ conductance under hypertonic stress
(plus 110 mosM) that was saturating at some 3 min of
exposure and readily reversible within comparable time
frames. Just like the HICC in primary hepatocytes [20], the
HepG2 channel was inhibited by micromolar concentrations
of flufenamate as well as amiloride rendering the expression
of an identical type of ion conductance in both systems quite
likely [31, 32]. Accordingly, and given the sizeable rate of
proliferation achieved by HepG2 cells, we were focusing on
this cell line when aiming at the correlation of HICC
activation with cell growth in human hepatocytes.
In fact, we observed a dose-dependent decrease of cell
proliferation by flufenamate and amiloride (determined by
two independent assays) that was very similar to the
inhibition of the HICC. Automatic cell counting revealed
that, for amiloride, there was no deterioration of cells, at all,
that may contribute to these effects. For flufenamate,
however, we were dealing with some 45% of necrotic (or
late apoptotic cells) — but only for the highest concentra-
tion tested, namely, 300 μM. In other words, at 100 μM
and below, this was clearly not the case.
Altogether, the efficiency of amiloride in blocking HepG2
proliferation appeared to be more pronounced when com-
pared to that of flufenamate, which is in good agreement with
the patch-clamp data. Noteworthy, in the electrophysiological
experiments, the exposure time to flufenamate and amiloride
will certainly be much too short to lead to any deterioration of
cell membranes. Furthermore, in the whole-cell recordings,
any changes in membrane characteristics would immediately
become obvious.
In the concentration range tested, amiloride will also
have a certain impact on NHE1 [12], which, in principle,
may contribute to the observed inhibition of HepG2 cell
proliferation. Given the very similar inhibition profiles
obtained with flufenamate and amiloride (both in the patch-
clamp recordings as well as in the proliferation assays), we
considered a channel-mediated effect of both compounds to be
more likely. Indeed, by means of the specific siRNA directed
against α-ENaC, this could clearly shown to be the case.
Of note, only one out of the three siRNAs tested was
actually leading to the expected decrease in the expression
of α-ENaC in HepG2 cells (data not shown). With this
siRNA at hand, however, α-ENaC could be defined as one
of the functional elements of the HICC in human
hepatocytes, and the correlation of channel expression with
cell proliferation could be demonstrated (Figs. 5 and 6).
Moreover, siRNA silencing of α-ENaC led to a strong
inhibition of the response of HepG2 cells to hypertonic cell
shrinkage (Fig. 7), as it is expected from the prominent role
that the HICC was supposed to play in the RVI process of
this system [33]. Finally, reducing the expression of α-
ENaC significantly increased the apoptosis rate (Fig. 9c),
an effect that — together with the observed reduction of
HepG2 cell proliferation — is readily explained in terms of
the shift of cells from the G1 to the G2/M phase of the cell
cycle, as it was observed in the FACS analysis (Fig. 8).
It is known that the β- and γ-subunits of the ENaC
significantly contribute to overall conductance and the
proper insertion of the channel into the plasma membrane
[9, 11, 17]. In HepG2 cells, however, β- and γ-ENaC are
only detectable on the genomic but not on the mRNA level
(Wehner, unpublished results). It is quite obvious though
that, given the moderate affinity of the HICC for amiloride
and the low selectivity with a PNa/PK, which is close to
unity [20], α-ENaC can by no means be the only one
component contributing to HICC architecture. This is
because, for α-ENaC alone, PNa/PK ratios higher than 10
and IC50 values for amiloride inhibition as low as 100 nM
have been reported [9, 13, 16]. Of note, HepG2 cells do
express the δ-subunit of the ENaC, which, however, is very
similar to α-ENaC also concerning its amiloride-sensitivity
as well as its high selectivity of Na+ over K+ [15, 29]. On
the other hand, δ-ENaC exhibits a considerable polymor-
phism that awaits to be defined (Wehner, unpublished results;
see also [39]). It is also worth mentioning, in this context,
that none of the seven mutations of δ-ENaC identified in our
lab (data not shown) exhibits any homology to the anti-α-
siRNA used in the present study for α-ENaC silencing. In
other words, the effects of anti-α-siRNA will clearly be
related to silencing of α-ENaC with no effects on δ-ENaC
expectable, at all.
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Interestingly, there appeared to be a certain cross-
correlation between HICC activity and the Cl− conductance
of the HepG2 cell membrane. Already in the non-transfected
control cells, HICC activation was paralleled by a sizeable
increase in Cl− conductance (see Fig. 1a). Furthermore, Cl−
conductance was more than doubled upon siRNA silencing
of α-ENaC, both under isotonic as well as under hypertonic
conditions (Fig. 5). Of note, in this respect, is the observation
that the HICC in human hepatocytes exhibits a distinct
dependence on extracellular Cl− concentration (with an
apparent Km of some 90 mM), whereas it appears to have
little intrinsic Cl− permeability, if any [20]. Furthermore, the
hepatocyte HICC is found to be almost completely blocked
by 100 μM 5-nitro-2-(3-phenylpropylamino)-benzoic acid
(NPPB) and 4-acetamido-4′-isothiocyanostilbene-2,2′-
disulfonic acid (SITS), which are both established inhibitors
of various types of Cl− channels (Li and Wehner, unpub-
lished results). The actual mechanism behind the coupling of
HICC and Cl− channels (and its apparent sensitivity to the
expression level of α-ENaC) remains to be determined and
will require a complete characterization of the architecture of
the HICC, which is currently under way.
In essence, we observe a prominent increase in HepG2
whole-cell Na+ currents in response to hypertonic stress that
is inhibited by HICC blockers and siRNA silencing of α-
ENaC. Channel inhibition is paralleled by a decrease in cell
proliferation, whereas the rate of apoptosis is actually
increasing. It is concluded that α-ENaC is a functional
component of the HICC in HepG2 cells, which is operating
in cell volume regulation as well as in cell proliferation.
HICC inhibition and apoptosis induction appear to be
related to an arrest of cells in the G2 phase of the mitotic
cycle. To the best of our knowledge, this is the first report
on a role of α-ENaC in cell proliferation.
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